AIRTO member Lucideon is excited to announce the launch of its new in vitro cell biology laboratory, further enhancing its materials consultancy and commercialisation capabilities. This new facility allows Lucideon to deliver essential cell biology testing in-house, offering clients comprehensive support for pharmaceutical and biotechnology product development and process improvement.
Recognising the growing demand for healthcare-related offerings, Lucideon identified the need to integrate cell biology expertise alongside its established strengths in chemical and physical materials testing. Establishing this capability has been made possible through a successful partnership with the School of Engineering and Materials Science (SEMS) at Queen Mary University of London (QMUL).
Through a Knowledge Transfer Partnership (KTP), partially funded by the UK Government, Lucideon hosted a highly experienced post-doctoral researcher for 30 months on-site with the aim of transferring advanced cell biology expertise to the Lucideon team. This collaboration builds on a long-standing relationship with SEMS, which has previously supported Lucideon’s projects in developing healthcare and implant materials.
